{
  "retracted": false,
  "timestamp": 1573862400000,
  "updates": [
    {
      "timestamp": 1573886474371,
      "identifier": {
        "doi": "10.1007/s10549-019-05498-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10549-019-05454-y"
  },
  "journal": "Breast Cancer Research and Treatment",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-Î± degrader activity in antitumor efficacy"
}
